Cannara Biotech (TSXV:LOVE) EPS (Diluted) : C$0.06 (TTM As of Feb. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Cannara Biotech EPS (Diluted)?

Cannara Biotech's Earnings per Share (Diluted) for the three months ended in Feb. 2024 was C$-0.04. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.06.

Cannara Biotech's EPS (Basic) for the three months ended in Feb. 2024 was C$-0.04. Its EPS (Basic) for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.06.

Cannara Biotech's EPS without NRI for the three months ended in Feb. 2024 was C$-0.04. Its EPS without NRI for the trailing twelve months (TTM) ended in Feb. 2024 was C$0.06.

During the past 12 months, Cannara Biotech's average EPS without NRIGrowth Rate was 76.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 6 years, Cannara Biotech's highest 3-Year average EPS without NRI Growth Rate was -48.40% per year. The lowest was -48.40% per year. And the median was -48.40% per year.

Cannara Biotech EPS (Diluted) Historical Data

The historical data trend for Cannara Biotech's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cannara Biotech EPS (Diluted) Chart

Cannara Biotech Annual Data

Trend

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

EPS (Diluted)

Get a 7-Day Free Trial

-0.20

-0.10

0.03

0.08

Cannara Biotech Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
EPS (Diluted)	Get a 7-Day Free Trial															-0.01	0.03	0.05	0.02	-0.04

Competitive Comparison of Cannara Biotech's EPS (Diluted)

For the Drug Manufacturers - Specialty & Generic subindustry, Cannara Biotech's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cannara Biotech's PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Cannara Biotech's PE Ratio distribution charts can be found below:

* The bar in red indicates where Cannara Biotech's PE Ratio falls into.

Cannara Biotech EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Cannara Biotech's Diluted EPS for the fiscal year that ended in Aug. 2023 is calculated as

Diluted EPS (A: Aug. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(6.945	-	0)	/	89.300
	=	0.08

Cannara Biotech's Diluted EPS for the quarter that ended in Feb. 2024 is calculated as

Diluted EPS (Q: Feb. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-3.447	-	0)	/	90.019
	=	-0.04

EPS (Diluted) for the trailing twelve months (TTM) ended in Feb. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was C$0.06

Cannara Biotech (TSXV:LOVE) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Cannara Biotech EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Cannara Biotech's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Cannara Biotech (TSXV:LOVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cannara Biotech Inc (TSXV:LOVE) » Definitions » EPS (Diluted)

Comparable Companies

Traded in Other Exchanges

LOVFF:USA 8CB0:Germany

Address

1055 West Georgia Street, Suite 2050, Vancouver, BC, CAN, V6E 3P3

Website

http://www.cannara.ca

Cannara Biotech Inc is a vertically integrated producer of premium-grade cannabis and cannabis-derivative products for Canadian markets. The company owns two mega Quebec-based facilities. The company operates in in two segments; Indoor cannabis operations segment which includes the cultivation, processing and sale of dried cannabis and cannabis derivatives for the Canadian market and the Real estate operations segment related to the Farnham and Valleyfield building. Majority of the revenue for the company is generated from its Cannabis operations segment. .

Executives